Apple Inc. (AAPL)

Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.

Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.

Share reduction while VUZI is at 0.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.

Reduced diluted shares while VUZI is at 0.15%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.

Dividend growth of 6.05% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.

Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.

Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.

Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.

10Y OCF/share CAGR above 1.5x VUZI's 56.80%. David Dodd would check if a superior product mix or cost edge drives this outperformance.

5Y OCF/share CAGR above 1.5x VUZI's 32.53%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.

Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.

Net income/share CAGR above 1.5x VUZI's 32.82% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.

5Y net income/share CAGR above 1.5x VUZI's 0.57%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.

Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.

Dividend/share CAGR of 124.36% while VUZI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.

Dividend/share CAGR of 31.08% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.

3Y dividend/share CAGR of 15.69% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.

Inventory is declining while VUZI stands at 3.97%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.

Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.

Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.

Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.

Our R&D shrinks while VUZI invests at 2.68%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.

We cut SG&A while VUZI invests at 7.81%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.